Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2013
10/10/2013US20130267607 Laxative gel composition
10/10/2013US20130267595 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/10/2013US20130267593 Methods and compositions for administration of oxybutynin
10/10/2013US20130267585 Pharmaceutical composition having a cationic excipient
10/10/2013US20130267560 Sustained release pharmaceutical compositions of donepezil
10/10/2013US20130267553 Liquid pharmaceutical formulations of palonosetron
10/10/2013US20130267505 Pharmaceutical compositions comprising benzyl alcohol
10/10/2013US20130267503 Pharmaceutical compositions comprising fatty acid esters
10/10/2013US20130266914 Strip for transferring a therapeutic composition to a tooth
10/10/2013US20130266721 Preparation of controlled drug release porous hydroxyapatite microspheres with interconnected pore channels
10/10/2013US20130266661 Amphiphilic cyclic phosphazene trimer, pharmaceutical formulation of hydrophobic drugs by micelle-encapsulation using the amphiphilic cyclic phosphazene trimer, and preparation methods thereof
10/10/2013US20130266660 Alcohol-resistant metoprolol-containing extended-release oral dosage forms
10/10/2013US20130266656 Amphiphilic compounds
10/10/2013US20130266655 Process for producing a marine mineral concentrate made from lithothamnium seaweed, and the marine mineral concentrate obtained therefrom
10/10/2013US20130266654 Method for treatment of acne using pharmaceutical compositions of clindamycin
10/10/2013US20130266653 Monovalent metal cation dry powders for inhalation
10/10/2013US20130266651 Long acting dual release product containing carbinoxamine and pseudoephedrine
10/10/2013US20130266648 Tableted compositions containing atazanavir
10/10/2013US20130266647 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/10/2013US20130266639 METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING BIFUNCTIONAL SRC 3 shRNA
10/10/2013US20130266633 Transdermal Therapeutic System
10/10/2013US20130266632 Drug delivery system based on polyethylene vinylacetate copolymers
10/10/2013US20130266631 Clonidine compounds in a biodegradable matrix
10/10/2013US20130266627 Method for Treating Mammals for Uterine Disorders with Therapeutic Nanolipidic Vehicles
10/10/2013US20130266616 Method of manufacturing bone graft materials and bone graft materials manufactured thereby
10/10/2013US20130266615 Non-immunogenic delivery vehicle for beta-, gamma-, and delta-tocopherols and methods of using and making same
10/10/2013US20130266614 Lipid carrier for delivery of bioactive substance and pharmaceutical composition
10/10/2013US20130266549 Highly biocompatible dual thermogelling chitosan/glucosamine salt composition
10/10/2013US20130266520 Oral film dosage form having physical-chemical identifier thereon
10/10/2013US20130266518 Methods and Compositions for Using Bleomycin-Derivatized Microbubbles
10/10/2013US20130266509 Method for coating and functionalizing nanoparticles by means of a michael reaction
10/10/2013US20130266508 Thermosensitive hydrogel for coating radioisotope and chemotherapeutic agent to treat cancer and method for preparing the same
10/10/2013US20130263852 Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
10/10/2013DE102012205493A1 Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem A dopamine agonist-containing transdermal delivery system
10/10/2013DE102012102414A1 Composition, used to treat diabetes mellitus, includes antidiabetic drug as active substance, preferably metformin or its salt, where the composition is divided into two compartments, which include drug and three groups of adjuvants
10/09/2013EP2647712A2 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
10/09/2013EP2647648A1 Hydroxyalkyl cellulose
10/09/2013EP2647397A1 Acidic concentrate for dialysis
10/09/2013EP2647386A1 Lissencephaly therapeutic agent
10/09/2013EP2647383A1 Breast enhancement accelerator
10/09/2013EP2647381A1 Orally disintegrating tablet
10/09/2013EP2647380A2 Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
10/09/2013EP2647371A1 A transmucosal delivery system
10/09/2013EP2647370A1 Transfusion preparation
10/09/2013EP2647369A1 Use of pacap for treating viral infections in aquatic organisms
10/09/2013EP2646501A1 Biodegradable natural films based on co-products derived from industrial seed-processing processes
10/09/2013EP2646115A2 Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails
10/09/2013EP2646107A2 Agent delivery systems for selective neuromodulation
10/09/2013EP2646052A2 Lyophilized viral formulations
10/09/2013EP2646051A2 Liquid viral formulations
10/09/2013EP2646040A1 Priming solutions for cardiopulmonary bypass
10/09/2013EP2646039A1 A composition and use thereof in the treatment of anal rhagades
10/09/2013EP2646036A1 Topical compositions for preserving or restoring the integrity of mucosae
10/09/2013EP2646017A2 Compounds and methods for skin repair
10/09/2013EP2646009A1 Rotigotine ionic liquid
10/09/2013EP2646008A1 Transdermal therapeutic system (tts) comprising rotigotine
10/09/2013EP2646007A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
10/09/2013EP2646006A1 A pharmaceutical dosage form
10/09/2013EP2646005A1 Compressed formulations of ordered mesoporous silicas
10/09/2013EP2646004A2 Galenic composition suitable for administration to a non-human animal, uses thereof, and associated methods
10/09/2013EP2646003A2 Rapidly dispersing granules, orally disintegrating tablets and methods
10/09/2013EP2646001A2 Formulation of lacosamide
10/09/2013EP2646000A1 Chemoembolization composition comprising anti-angiogenic agents
10/09/2013EP2645999A2 Pharmaceutical compositions
10/09/2013EP2645998A2 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
10/09/2013EP2645997A2 Once daily formulation of lacosamide
10/09/2013EP2645996A2 Process for the preparation of a ppi-containing pharmaceutical product
10/09/2013EP2645995A1 Capsule and powder formulations containing lanthanum compounds
10/09/2013EP2645994A2 Formulations comprising methylthioninium chloride
10/09/2013EP2645993A2 Pharmaceutical cream compositions comprising oxymetazoline
10/09/2013EP2645992A2 Solid dosage form that promotes reliable oral, esophageal and gi transit
10/09/2013EP2645991A2 Aptamer bioconjugate drug delivery device
10/09/2013EP2645878A1 Prevention or treatment of overweight and obesity in type 2 diabetic patients
10/09/2013CN203227048U Dry-coated tablet as anti-tumor agent
10/09/2013CN203227047U Composite medicament bonding device
10/09/2013CN103347931A Producing powdery coating agents for stable protective coatings for pharmaceutical dosage forms
10/09/2013CN103347543A Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same
10/09/2013CN103347541A Production method for adhesive patch
10/09/2013CN103347535A Liquid viral formulations
10/09/2013CN103347533A Citrate free pharmaceutical compositions comprising anakinra
10/09/2013CN103347522A 透皮贴剂 Transdermal patches
10/09/2013CN103347518A Liquid propellant-free formulation comprising an antimuscarinic drug
10/09/2013CN103347504A 贴剂及贴剂制剂 Patch and patch preparation
10/09/2013CN103347503A Effervescent gamma-hydroxybutyric acid granules
10/09/2013CN103347502A Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof
10/09/2013CN103347501A Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
10/09/2013CN103347500A Compositions and methods for treatment of taupathy
10/09/2013CN103347499A Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
10/09/2013CN103347498A Pharmaceutical formulation for histone deacetylase inhibitors
10/09/2013CN103347497A Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
10/09/2013CN103347496A Drug delivery dispersion and film formed therefrom
10/09/2013CN103347495A Combination of opioid agonist and opioid antagonist in treatment of parkinson's disease
10/09/2013CN103347494A Oral vaccine fast-dissolving dosage form using starch
10/09/2013CN103347493A Compositions and methods for treating cardiovascular disease
10/09/2013CN103342805A Nonlinear polyethylene glycol-polyester copolymer, nonlinear polyethylene glycol-polyester copolymer micelle and preparation method of medicine carrying micelle
10/09/2013CN103342788A Triblock polycation, and preparation method and application thereof
10/09/2013CN103341180A Targeted liposome drug delivery system used for tumor imaging, preparation method and application
10/09/2013CN103341175A Preparation method of fibroin microsphere
10/09/2013CN103341174A Method for screening pulsatile sustained release material used for Xuesaitong (name of Chinese medicine) medicine
10/09/2013CN103341170A Dual-controllable medicine release structure with SERS (Surface Enhanced Raman Scattering) signal and preparation method of dual-controllable medicine release structure
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 2991